31.07.2013 Views

2011 ADA Posters 1261-2041.indd - Diabetes

2011 ADA Posters 1261-2041.indd - Diabetes

2011 ADA Posters 1261-2041.indd - Diabetes

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Integrated Physiology/<br />

Obesity<br />

POSTERS<br />

1902-P<br />

Intentional Weight Loss Is Associated with Increased Total and<br />

High Molecular Weight Adiponectin in Men and Women with Type<br />

2 <strong>Diabetes</strong> in Look AHEAD (Action for Health in <strong>Diabetes</strong>); Findings<br />

on Fitness and Adiposity Change<br />

L. MARIA BELALCAZAR, STEVEN M. HAFFNER, WEI LANG, RON C. HOOGEVEEN,<br />

KATHERINE M. DONADIO, DAWN C. SCHWENKE, F. XAVIER PI-SUNYER, RUSSELL<br />

P. TRACY, ANDREA M. KRISKA, CHRISTIE M. BALLANTYNE, Galveston, TX, Houston,<br />

TX, Winston-Salem, NC, Phoenix, AZ, New York, NY, Burlington, VT, Pittsburgh, PA<br />

Adiponectin and particularly high molecular weight adiponectin (HMW-A)<br />

levels are low in people with type 2 diabetes. Little is known about the<br />

differential effects of weight loss and increased fi tness on total and HMW-A<br />

in obese diabetic persons. In a subset of 1,397 Look AHEAD participants (with<br />

characteristics similar to the whole sample) we evaluated the effects of a<br />

1-year intensive lifestyle intervention for weight loss (ILI) and of usual care<br />

(<strong>Diabetes</strong> Support and Educations [DSE]) on total and HMW-A levels using a<br />

quantitative ELISA and investigated the independent contribution of adiposity<br />

and fi tness changes on their levels. Look AHEAD is a randomized trial evaluating<br />

whether ILI will reduce cardiovascular events/mortality when compared to<br />

DSE in obese type 2 diabetic persons. Subjects (mean age 57.2 years; BMI<br />

36.3 kg/m 2 ; submaximal fi tness 5.2 METS) had baseline total and HMW-A<br />

levels (median [interquartile range]) of 4.1 (3.0, 5.8) and 1.6 (1.0, 2.7) in men<br />

and 5.1 (3.8, 7.5) and 2.2 (1.4, 3.5) µg/mL in women, respectively. At 1-year, ILI<br />

participants lost 8% of baseline weight and increased fi tness by 21% (vs 0.6%<br />

and 6% in DSE, respectively). ILI increased baseline total adiponectin by 24%<br />

in men and 6% in women and HMW-A by 36% and 15% in men and women,<br />

respectively (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!